(Q37080228)

18 August 2017

Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis (English)

1 reference

18 August 2017

0 references

0 references

0 references

16

1 reference

18 August 2017

M O Harris-Love

1

1 reference

18 August 2017

J A Shrader

2

1 reference

18 August 2017

D Koziol

3

1 reference

18 August 2017

N Pahlajani

4

1 reference

18 August 2017

M Jain

5

1 reference

18 August 2017

M Smith

6

1 reference

18 August 2017

H L Cintas

7

1 reference

18 August 2017

C L McGarvey

8

1 reference

18 August 2017

L James-Newton

9

1 reference

18 August 2017

A Pokrovnichka

10

1 reference

18 August 2017

B Moini

11

1 reference

18 August 2017

I Cabalar

12

1 reference

18 August 2017

D J Lovell

13

1 reference

18 August 2017

R Wesley

14

1 reference

18 August 2017

P H Plotz

15

1 reference

18 August 2017

J E Hicks

17

1 reference

18 August 2017

L G Rider

18

1 reference

18 August 2017

11 December 2008

1 reference

18 August 2017

1 reference

18 August 2017

48

1 reference

18 August 2017

2

1 reference

18 August 2017

134-139

1 reference

Long-term outcome in polymyositis and dermatomyositis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Adult inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Physical activity and disablement in the idiopathic inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis and dermatomyositis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Defining Clinical Improvement in Adult and Juvenile Myositis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Immunoglobulin therapy in inflammatory myopathies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis-dermatomyositis--a 25-year follow-up of 50 patients (analysis of clinical symptoms and signs and results of laboratory tests).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis and dermatomyositis (second of two parts)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Assessment of muscle strength in children with meningomyelocele: accuracy and stability of measurements over time.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polyarticular disability: a functional assessment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Prognosis and mortality of polymyositis and dermatomyositis patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Survival, mortality and causes of death in inflammatory myopathies

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN441

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN441

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN441

Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634286

Relationship of knee extension force to independence in sit-to-stand performance in patients receiving acute rehabilitation

4 December 2018

1 reference

12 December 2020

Walking ability and its relationship to lower-extremity muscle strength in children with idiopathic inflammatory myopathies11The opinions expressed in this article reflect the views of the authors and are not necessarily those of the National Institu

1 reference

12 December 2020

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

12 December 2020

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

1 reference

12 December 2020

Analysis of the outcome of idiopathic inflammatory myopathies with particular emphasis on muscle capillary damage

1 reference

12 December 2020

The relationship of strength to function in the older adult

1 reference

12 December 2020

Long-term prognosis of 69 patients with dermatomyositis or polymyositis

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

1 reference

12 December 2020

A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures

1 reference

12 December 2020

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyos

1 reference

12 December 2020

National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis

1 reference

12 December 2020

10.1093/RHEUMATOLOGY/KEN441

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19074186

1 reference